Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Sanofi
02 4Alfred E Tiefenbacher GmbH
03 2Olpha
04 2medac
05 2AOP Health
06 10Accord healthcare
07 2Actavis Inc
08 2Alembic Pharmaceuticals Limited
09 8Alphapharm PTY Ltd
10 4Apotex Inc
11 2Aristo Pharma GmbH
12 8Arrotex Pharmaceuticals
13 2Aurobindo Pharma Limited
14 2Aurovitas Spain, Sau
15 4Bluefish Pharmaceuticals AB
16 4Cipla
17 2Cipla Medpro South Africa
18 2Deva Holding AS
19 2Devatis AG
20 24GSK
21 2Gilead Sciences
22 2Indoco Remedies Limited
23 2Inteli Generics Nord Uab
24 2Kern Pharma S.L.
25 2Mepha Pharma
26 2Norameda
27 2OrPha Swiss
28 2PH HEALTH
29 2Reig Jofre
30 10Sandoz B2B
31 16Seekwell
32 2Sigmapharm Laboratories, LLC
33 2Sun Pharmaceutical Industries Limited
34 6Teva Pharmaceutical Industries
35 12Viatris
36 2Vivanta Generics Sro
37 4Zentiva
38 2Zydus Pharmaceuticals
01 1Ambrisentan 10Mg 30 Joined' Oral Use
02 1Ambrisentan 5Mg 30 Joined' Oral Use
03 4FCT
04 69Film Coated Tablet
05 2Film Coated Tablet - Oral
06 13Film-Coated Tablet
07 2Film-Coated Tablet For Oral Use,
08 8Film-Coated Tablets
09 6TABLET
10 20TABLET;ORAL
11 6Tablet
12 32tablet
01 10Allowed
02 11Approved
03 19Authorized
04 6Cancelled
05 2DISCN
06 2Deregistered
07 6Generic
08 5Marketed
09 1Not Marketed
10 2Originator
11 30Prescription
12 18RX
13 4Status- Under Registration
14 2Suspended
15 46Blank
01 18AMBRISENTAN
02 2AMBRISENTAN ACCORD
03 2AMBRISENTAN MEDAC
04 2AMBRISENTAN MYLAN
05 2AMBRISENTAN TEVA
06 2AMBRISENTAN ZENTIVA ITALY
07 2APO-AMBRISENTAN
08 2Ambient Aristo
09 6Ambrisentan Accord
10 2Ambrisentan Alembic
11 2Ambrisentan Aop
12 2Ambrisentan Aurovitas
13 4Ambrisentan Bluefish
14 2Ambrisentan Cipla
15 2Ambrisentan Devatis
16 2Ambrisentan Inteli
17 2Ambrisentan Kern Pharma
18 2Ambrisentan Norameda
19 2Ambrisentan Olpha
20 2Ambrisentan Orpha
21 2Ambrisentan Sala
22 6Ambrisentan Sandoz
23 2Ambrisentan Teva
24 16Ambrisentan Viatris
25 2Ambrisentan Vivanta
26 4Ambrisentan Zentiva
27 2Ambrisentan "Accord"
28 2Ambrisentan "Sandoz"
29 2Ambrisentan "Teva"
30 2Ambrisentan-Mepha
31 8Cipla Ambrisentan
32 2LETAIRIS
33 8PULMORIS
34 2SANDOZ AMBRISENTAN TABLETS
35 4VOLIBRIS
36 26Volibris
37 1Volibris 10 mg
38 1Volibris 5 mg
39 1Volmaro 10
40 1Volmaro 5
41 8Blank
01 32Australia
02 6Canada
03 11Denmark
04 13Estonia
05 4Germany
06 2India
07 14Italy
08 6Norway
09 4South Africa
10 27Spain
11 13Sweden
12 10Switzerland
13 2Turkey
14 20USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Ambrisentan Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 10/05/2021
Application Number : 67734
Regulatory Info : Allowed
Registration Country : Switzerland
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ambrisentan Olpha
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 28-11-2025
Application Number : 90664
Regulatory Info : Authorized
Registration Country : Spain
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN MEDAC
Dosage Form : Film-Coated Tablets
Dosage Strength : 10 mg
Packaging : 30 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Ambrisentan Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 10/05/2021
Application Number : 67734
Regulatory Info : Allowed
Registration Country : Switzerland
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ambrisentan Olpha
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date : 28-11-2025
Application Number : 90665
Regulatory Info : Authorized
Registration Country : Spain
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN MEDAC
Dosage Form : Film-Coated Tablets
Dosage Strength : 5 mg
Packaging : 30 UNITS 5 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LETAIRIS
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2007-06-15
Application Number : 22081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LETAIRIS
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2007-06-15
Application Number : 22081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-04-10
Application Number : 208354
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-04-10
Application Number : 208354
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208441
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208441
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-04-10
Application Number : 209509
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-04-10
Application Number : 209509
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
